Friday, July 10, 2026

Drug profile · INN

darvadstrocel

darvadstrocel (ALOFISEL) is a unknown. Associated with Takeda.

EMA: withdrawn Antineoplastic and immunomodulating agents (L04) L04
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — darvadstrocel
Class
Antineoplastic and immunomodulating agents (L04)
Route
Patents
0
Programs
3
Data quality
0.89

Quick answer

darvadstrocel (ALOFISEL) is a unknown. Associated with Takeda.

Key facts

INN darvadstrocel
Brand ALOFISEL
Mechanism Unknown
Therapeutic class Antineoplastic and immunomodulating agents (L04)
ATC code L04
Originator Takeda

Mechanism of action

Unknown

Approval history

Authority Status Date
EMA withdrawn

Pipeline programs

  1. Darvadstrocel Phase 3 · Takeda · Complex Perianal Fistulas in Adult Participants With Crohn's
  2. Alofisel 5 × 106 cells/mL dispersion for injection. Approved · Takeda · Perianal fistulising Crohn´s disease
  3. Darvadstrocel Approved · Takeda · Crohn's Disease

Related & competitor drugs

  1. abiraterone acetate Antineoplastic and immunomodulating agents (L02)
  2. anagrelide Antineoplastic and immunomodulating agents (L01)
  3. apremilast Antineoplastic and immunomodulating agents (L04)
  4. arsenic trioxide Antineoplastic and immunomodulating agents (L01)
  5. axitinib Antineoplastic and immunomodulating agents (L01)
  6. azacitidine Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is darvadstrocel?

darvadstrocel (ALOFISEL) is a unknown. Associated with Takeda.

What is the brand name for darvadstrocel?

ALOFISEL is a marketed brand name for darvadstrocel. Check FDA Drugs@FDA for the current US label holder and prescribing information.